Accessibility Menu
Sharps Technology logo

Sharps Technology(NASDAQ) STSS

Market Cap$52.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-100%
5 YearN/A
1 Year-81%
1 Month+8%
$1.25
+3.31%
+0.04Today
After hours$1.25+$0.00 (+0.00%)
Sharps Technology last closing stock price
MetricPriceDate
Last closeUSD 1.252026-08-10
Sharps Technology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.1%USD 1.292026-08-03
1 month+7.76%USD 1.162026-07-10
3 month-37.5%USD 2.002026-05-12
Year to date-38.42%USD 2.032025-12-31
1 year-80.77%USD 6.502025-08-08
3 year-99.98%USD 5,486.582023-08-11
Since inception-99.99%USD 13,926.152022-04-14

Sharps Technology Financials at a Glance

Market Cap

$52.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.50M

Net Income (TTM)

-$397.51M

EPS (TTM)

-$12.10

P/E Ratio

-0.10

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.25

Volume

13

Open

$1.20

Previous Close

$1.25

Daily Range

$1.15 - $1.25

52-Week Range

$0.91 - $18.23

Estimated Earnings Date

Sep 2, 2026

STSS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sharps Technology

Sharps makes syringes for hospitals and clinics to safely deliver vaccines and medicines. The company also manages digital assets, mainly Solana, to generate income. Its products help healthcare providers reduce waste and improve safety.

Products and Services

  • Safety Syringes: Ultra-low waste syringes for vaccines and medicines; used by hospitals and clinics.
  • Securgard and Sologard Syringes: Syringe lines for safe drug delivery; target healthcare providers and medical supply firms.
  • Digital Asset Treasury: Manages Solana (SOL) digital assets; generates income primarily through staking.
  • Staking Services: Earns rewards by staking SOL with multiple validators, including Coinbase; supports treasury income.
  • Stablecoin Holdings: Holds USDC and USDT for liquidity and settlements; supports digital asset operations.

Growth and Expansion

  • In 2025, spun off Hungarian manufacturing subsidiary and exited in-house production.
  • Launched digital asset treasury strategy in August 2025, focusing on Solana.
  • Raised $411 million in August 2025 via PIPE offering, including cash and digital assets.
  • Started share repurchase program in 2025, authorizing up to $100 million.
  • Expanded product sales to both U.S. and international healthcare markets in 2025.

What Makes Sharps Stand Out

Sharps combines medical device sales with a digital asset treasury, a rare mix in healthcare. Its treasury is highly concentrated in Solana, with most assets staked for yield. The company uses strict risk controls and diversified custodians to manage digital asset exposure.

Five Things You Need to Know

  • Digital asset treasury made up approximately 97% of 2025 revenue.
  • Medical device sales began in 2025, contributing approximately 3% of revenue.
  • Operating loss was $269.7 million in 2025, up approximately 4,750% from 2024.
  • Unrealized loss on digital assets was $152.95 million in 2025.

Bottom Line

Sharps shifted from medical device manufacturing to a dual focus on device sales and digital asset management. The company’s evolution highlights adaptability and a unique approach to treasury management in healthcare.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

55

CEO

Paul K. Danner, III, MBA

Website

www.theskyai.co

Headquarters

Melville, NY 11747, US

STSS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

11.97%

Return on Capital

-4.97%

Return on Assets

11.19%

Earnings Yield

-10.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$52.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

42.32M

Volume

13

Avg. Volume

241.72K

Financials (TTM)

Gross Profit

$324.68K

Operating Income

-$36.22M

EBITDA

-$369.04M

Operating Cash Flow

-$16.95M

Capital Expenditure

-$186.01M

Free Cash Flow

-$202.96M

Cash & ST Invst.

$12.07M

Total Debt

$0.00

Sharps Technology Performance Analysis

Sharps Technology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 7,009,129N/A
Sharps Technology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-62.5%
Q42025-12-31-222.2%
Q12026-03-31288.6%
Q22026-06-301105.3%
Sharps Technology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3,780.2812.6%
20232023-12-31USD -4,983.9931.8%
20242024-12-31USD -2,219.50-55.5%
20252025-12-31USD -11.12-99.5%
Sharps Technology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-220.9%
Q42025-12-31-44.6%
Q12026-03-3181.0%
Q22026-06-3073.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.32M

+943.2%

Gross Profit

-$284.23K

+72.5%

Gross Margin

-12.23%

N/A

Market Cap

$52.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$961.87K

N/A

Employees

55

N/A

Net Income

-$23.28M

-754.1%

EBITDA

-$23.39M

-732.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$12.07M

+45.0%

Total Debt

$0.00

N/A

Accounts Receivable

$396.90K

-9.7%

Inventory

$173.48K

-89.4%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

11.19%

N/A

Return on Invested Capital

-0.37%

N/A

Free Cash Flow

-$2.68M

-5.4%

Operating Cash Flow

-$2.68M

-9.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AGPUAxe Compute Inc.
$8.41+0.12%
HSCSHeartSciences Inc.
$2.07+2.48%
HTCRHeartCore Enterprises, Inc.
$2.85+4.01%
NXGLNEXGEL, Inc.
$0.36-4.63%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$97.52-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.80-0.01%
NVDANvidia
$217.55-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.73+0.01%

Questions About STSS

What is the current price of Sharps Technology?

Sharps Technology is trading at $1.25 per share.

What is the 52-week range for Sharps Technology?

Over the past 52 weeks, Sharps Technology has traded between $0.91 and $18.23.

How much debt does Sharps Technology have?

As of the most recent reporting period, Sharps Technology reported total debt of $302.68K.

How much cash does Sharps Technology have on hand?

Sharps Technology reported $12.07M in cash and cash equivalents in its most recent financial results.

What is Sharps Technology’s dividend yield?

Sharps Technology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services